Literature DB >> 17904756

A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.

G W Arendash1, M T Jensen, N Salem, N Hussein, J Cracchiolo, A Dickson, R Leighty, H Potter.   

Abstract

Although a number of epidemiologic studies reported that higher intake of omega-3 fatty acids (largely associated with fish consumption) is protective against Alzheimer's disease (AD), other human studies reported no such effect. Because retrospective human studies are problematic and controlled longitudinal studies over decades are impractical, the present study utilized Alzheimer's transgenic mice (Tg) in a highly controlled study to determine whether a diet high in omega-3 fatty acid, equivalent to the 13% omega-3 fatty acid diet of Greenland Eskimos, can improve cognitive performance or protect against cognitive impairment. Amyloid precursor protein (APP)-sw+PS1 double transgenic mice, as well as nontransgenic (NT) normal littermates, were given a high omega-3 supplemented diet or a standard diet from 2 through 9 months of age, with a comprehensive behavioral test battery administered during the final 6 weeks. For both Tg and NT mice, long-term n-3 supplementation resulted in cognitive performance that was no better than that of mice fed a standard diet. In NT mice, the high omega-3 diet increased cortical levels of omega-3 fatty acids while decreasing omega-6 levels. However, the high omega-3 diet had no effect on cortical fatty acid levels in Tg mice. Irrespective of diet, no correlations existed between brain omega-3 levels and cognitive performance for individual NT or Tg mice. In contrast, brain levels of omega-6 fatty acids were strongly correlated with cognitive impairment for both genotypes. Thus, elevated brain levels of omega-3 fatty acids were not relevant to cognitive function, whereas high brain levels of omega-6 were associated with impaired cognitive function. In Tg mice, the omega-3 supplemental diet did not induce significant changes in soluble/insoluble Abeta within the hippocampus, although strong correlations were evident between hippocampal Abeta(1-40) levels and cognitive impairment. While these studies involved a genetically manipulated mouse model of AD, our results suggest that diets high in omega-3 fatty acids, or use of fish oil supplements (DHA+EPA), will not protect against AD, at least in high-risk individuals. However, normal individuals conceivably could derive cognitive benefits from high omega-3 intake if it corrects an elevation in the brain level of n-6 fatty acids as a result. Alternatively, dietary fish may contain nutrients, other than DHA and EPA, that could provide some protection against AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904756     DOI: 10.1016/j.neuroscience.2007.08.018

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  35 in total

Review 1.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  DHA may prevent age-related dementia.

Authors:  Greg M Cole; Sally A Frautschy
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

Review 3.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Consumption of fish and Alzheimer's disease.

Authors:  W Newton; A McManus
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

5.  Omega-3 fatty acids revert high-fat diet-induced neuroinflammation but not recognition memory impairment in rats.

Authors:  Aline Marcelino de Andrade; Marilda da Cruz Fernandes; Luciano Stürmer de Fraga; Marilene Porawski; Márcia Giovenardi; Renata Padilha Guedes
Journal:  Metab Brain Dis       Date:  2017-07-29       Impact factor: 3.584

6.  Caloric restriction improves memory in elderly humans.

Authors:  A V Witte; M Fobker; R Gellner; S Knecht; A Flöel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

7.  Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing.

Authors:  Yan Lu; Haibin Tian; Song Hong
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

8.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

9.  Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Authors:  Arzu Ulu; Todd R Harris; Christophe Morisseau; Christina Miyabe; Hiromi Inoue; Gertrud Schuster; Hua Dong; Ana-Maria Iosif; Jun-Yan Liu; Robert H Weiss; Nipavan Chiamvimonvat; John D Imig; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

10.  Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain.

Authors:  Paul H Axelsen; Robert C Murphy
Journal:  J Lipid Res       Date:  2009-09-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.